Organovo logo

Organovo Share Price Today

(NASDAQ: ONVO)

Organovo share price is $0.54 & ₹46.96 as on 6 Mar 2025, 2.30 'hrs' IST

$0.54

-0.07

(-11.25%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Organovo share price in Dollar and Rupees. Guide to invest in Organovo stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Organovo, along with analyst recommendations, forecasts, and comprehensive financials.

Organovo share price movements

  • Today's Low: $0.52
    Today's High: $0.61

    Day's Volatility :14.15%

  • 52 Weeks Low: $0.32
    52 Weeks High: $1.83

    52 Weeks Volatility :82.77%

Organovo (ONVO) Returns

PeriodOrganovo Holdings IncSector (Health Care)Index (Russel 2000)
3 Months
35.43%
2.7%
0.0%
6 Months
7.43%
-3.7%
0.0%
1 Year
-40.49%
1.5%
0.0%
3 Years
-84.27%
11.8%
-11.6%

Organovo (ONVO) Key Statistics

in dollars & INR

Previous Close
$0.607
Open
$0.6
Today's High
$0.6069
Today's Low
$0.521
Market Capitalization
$10.6M
Today's Volume
$275.4K
52 Week High
$1.83
52 Week Low
$0.3154
Revenue TTM
$122.0K
EBITDA
$-12.3M
Earnings Per Share (EPS)
$-0.73
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-378.4%

How to invest in Organovo Stock (ONVO) from India?

It is very easy for Indian residents to invest directly in Organovo from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Organovo stock in both Indian Rupees (INR) and US Dollars (USD). Search for Organovo or ONVO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Organovo or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Organovo shares which would translate to 1.611 fractional shares of Organovo as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Organovo, in just a few clicks!

Returns in Organovo (ONVO) for Indian investors in Rupees

The Organovo stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Organovo investment value today

Current value as on today

₹57,890

Returns

₹42,110

(-42.11%)

Returns from Organovo Stock

₹47,059 (-47.06%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Organovo (ONVO)

1600.0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Organovo Shares from India has grown by 1600.0% over the past 30 days, indicating increased transactional activity.

743%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Organovo Stock from India on INDmoney has increased by 743% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Organovo

  • Armistice Capital, LLC

    9.39%

  • Prescott Group Capital Management LLC

    1.61%

  • BlackRock Inc

    0.81%

  • Geode Capital Management, LLC

    0.69%

  • Vanguard Group Inc

    0.66%

  • Renaissance Technologies Corp

    0.18%

Analyst Recommendation on Organovo

Hold

    0%Buy

    57%Hold

    42%Sell

Based on 7 Wall street analysts offering stock ratings for Organovo(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
4
4
4
Sell
3
3
3

Analyst Forecast on Organovo Stock (ONVO)

What analysts predicted

Upside of 900.0%

Target:

$5.40

Current:

$0.54

Insights on Organovo Stock (Ticker Symbol: ONVO)

  • Price Movement

    In the last 1 month, ONVO stock has moved up by 77.6%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 39.0K → 24.0K (in $), with an average decrease of 21.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -2.54M → -3.44M (in $), with an average decrease of 35.2% per quarter
  • ONVO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 102.8%
  • ONVO vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 132.2%
  • Price to Sales

    ForONVO every $1 of sales, investors are willing to pay $67.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Organovo Technicals Summary

Sell

Neutral

Buy

Organovo is currently in a neutral trading position according to technical analysis indicators.

Organovo (ONVO) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Organovo Holdings Inc logo
79.21%
7.43%
-40.49%
-84.27%
-88.85%
Regeneron Pharmaceuticals, Inc. logo
-3.09%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.43%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
0.82%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-10.36%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Organovo Holdings Inc logo
NA
NA
0.0
0.0
-3.78
-1.23
NA
0.02
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Organovo Holdings Inc logo
Hold
$10.6M
-88.85%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Organovo

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company's lead candidate is FXR314, which is phase 2/3clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus steatohepatitis. Organovo Holdings, Inc. has research collaborations with Yale School of Medicine, Knight Cancer Institute at Oregon Health & Science University, and the University of Virginia for research of NovoGen Bioprinters. The company was incorporated in 2007 and is headquartered in San Diego, California.
Organization
Organovo
Employees
14
CEO
Mr. Keith E. Murphy
Industry
Health Technology

Management People of Organovo

NameTitle
Mr. Keith E. Murphy
Executive Chairman & Corporate Secretary
Ms. Vaidehi Joshi
Director of Discovery Biology & Director
Mr. Norman Staskey
President, CFO & Principal Financial Officer
Dr. Curtis M. Tyree Ph.D.
Senior Vice President of Strategy & Business Development

Important FAQs about investing in ONVO Stock from India :

What is Organovo share price today?

Organovo share price today stands at $0.54, Open: $0.60 ; Previous Close: $0.61 ; High: $0.61 ; Low: $0.52 ; 52 Week High: $1.83 ; 52 Week Low: $0.32.

The stock opens at $0.60, after a previous close of $0.61. The stock reached a daily high of $0.61 and a low of $0.52, with a 52-week high of $1.83 and a 52-week low of $0.32.

Can Indians buy Organovo shares?

Yes, Indians can invest in the Organovo (ONVO) from India.

With INDmoney, you can buy Organovo at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Organovo at zero transaction cost.

How can I buy Organovo shares from India?

It is very easy to buy Organovo from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Organovo (ONVO) be purchased?

Yes, you can buy fractional shares of Organovo with INDmoney app.

What are the documents required to start investing in Organovo stocks?

To start investing in Organovo, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Organovo Stock (ONVO)?

Today’s highest price of Organovo (ONVO) is $0.61.

Today’s lowest price of Organovo (ONVO) is $0.52.

What is today's market capitalisation of Organovo?

Today's market capitalisation of Organovo ONVO is 10.6M

What is the 52 Week High and Low Range of Organovo Stock (ONVO)?

  • 52 Week High

    $1.83

  • 52 Week Low

    $0.32

What are the historical returns of Organovo (ONVO)?

  • 1 Month Returns

    79.21%

  • 3 Months Returns

    7.43%

  • 1 Year Returns

    -40.49%

  • 5 Years Returns

    -88.85%

Who is the Chief Executive Officer (CEO) of Organovo ?

Mr. Keith E. Murphy is the current Chief Executive Officer (CEO) of Organovo.